Trajectory patterns and cumulative burden of CEA during follow-up with non-small cell lung cancer outcomes: A retrospective longitudinal cohort study

被引:2
|
作者
Li, Chunxia [1 ]
Liu, Lizhu [2 ]
You, Ruimin [2 ]
Li, Yanli [2 ]
Pu, Hongjiang [3 ]
Lei, Ming [4 ]
Fan, Bingbing [1 ]
Lv, Jiali [1 ]
Liu, Mengmei [5 ]
Yan, Guanghong [5 ]
Li, Zhenhui [2 ]
You, Dingyun [5 ,6 ]
Zhang, Tao [1 ]
机构
[1] Shandong Univ, Cheeloo Coll Med, Sch Publ Hlth, Dept Biostat, Jinan 250012, Shandong, Peoples R China
[2] Kunming Med Univ, Affiliated Hosp 3, Yunnan Canc Hosp, Dept Radiol,Yunnan Canc Ctr, Kunming 650118, Peoples R China
[3] Kunming Med Univ, Affiliated Hosp 3, Yunnan Canc Hosp, Dept Colorectal Surg,Yunnan Canc Ctr, Kunming 650118, Peoples R China
[4] Kunming Med Univ, Affiliated Hosp 3, Yunnan Canc Hosp, Dept Clin Lab Med,Yunnan Canc Ctr, Kunming 650118, Peoples R China
[5] Kunming Med Univ, Sch Publ Hlth, Kunming 650500, Yunnan, Peoples R China
[6] Kunming Med Univ, Yunnan Prov Key Lab Publ Hlth & Biosafety, Kunming 650500, Yunnan, Peoples R China
基金
中国国家自然科学基金;
关键词
SERUM CARCINOEMBRYONIC ANTIGEN; PROGNOSTIC-SIGNIFICANCE; SURGERY; LEVEL;
D O I
10.1038/s41416-024-02678-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundPrevious studies of non-small cell lung cancer (NSCLC) focused on CEA measured at a single time point, ignoring serial CEA measurements.MethodsThis retrospective cohort included 2959 patients underwent surgery for stage I-III NSCLC. CEA trajectory patterns and long-term cumulative CEA burden were evaluated using the latent class growth mixture model.ResultsFour CEA trajectory groups were identified, named as low-stable, decreasing, early-rising and later-rising. Compared with the low-stable group, the adjusted hazard ratios associated with death were 1.27, 4.50, and 3.68 for the other groups. Cumulative CEA burden were positively associated with the risk of death in patients not belonging to the low-stable group. The 5-year overall survival (OS) rates decreased from 62.3% to 33.0% for the first and fourth quantile groups of cumulative CEA burden. Jointly, patients with decreasing CEA trajectory could be further divided into the decreasing & low and decreasing & high group, with 5-year OS rates to be 77.9% and 47.1%. Patients with rising CEA trajectory and high cumulative CEA were found to be more likely to develop bone metastasis.ConclusionsLongitudinal trajectory patterns and long-term cumulative burden of CEA were independent prognostic factors of NSCLC. We recommend CEA in postoperative surveillance of NSCLC.
引用
收藏
页码:1803 / 1808
页数:6
相关论文
共 50 条
  • [41] Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS)
    Andreas, Stefan
    Chouaid, Christos
    Danson, Sarah
    Siakpere, Obukohwo
    Benjamin, Laure
    Ehness, Rainer
    Drarnard-Goasdoue, Marie-Helene
    Barth, Janina
    Hoffmann, Hans
    Potter, Vanessa
    Barlesi, Fabrice
    Chirila, Costel
    Hollis, Kelly
    Sweeney, Carolyn
    Price, Mark
    Wolowacz, Sorrel
    Kaye, James A.
    Kontoudis, Ilias
    LUNG CANCER, 2018, 124 : 298 - 309
  • [42] Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: an exploratory longitudinal study
    Nuria Vinolas, N.
    Garcia-Campelo, Rosario
    Majem, Margarita
    Carcereny, Enric
    Isla, Dolores
    Luis Gonzalez-Larriba, Jose
    Coves, Juan
    De-Castro, Javier
    Domine, Manuel
    Lianes, Piar
    Artal, Angel
    Remon, Jordi
    Felip, Enriqueta
    Garrido, Pilar
    BMC PSYCHOLOGY, 2020, 8 (01)
  • [43] Temporal patterns of care and outcomes of non-small cell lung cancer patients in the United States diagnosed in 1996, 2005, and 2010
    Kaniski, Filip
    Enewold, Lindsey
    Thomas, Anish
    Malik, Shakuntala
    Stevens, Jennifer L.
    Harlan, Linda C.
    LUNG CANCER, 2017, 103 : 66 - 74
  • [44] Risk factors and outcomes of bronchopleural fistula after bronchoplasty in patients with non-small cell lung cancer: a retrospective multivariate analysis
    Peng, Zhiyu
    Mei, Jiandong
    Liu, Chengwu
    Guo, Chenglin
    Gonzalez, Michel
    Bolukbas, Servet
    Voltolini, Luca
    Pu, Qiang
    Liu, Lunxu
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (05) : 744 - +
  • [45] Treatment patterns and clinical outcomes of resectable clinical stage III non-small cell lung cancer in a Japanese real-world setting: Surgery cohort analysis of the SOLUTION study
    Tsuboi, Masahiro
    Murakami, Haruyasu
    Harada, Hideyuki
    Sobue, Tomotaka
    Kato, Tomohiro
    Atagi, Shinji
    Tokito, Takaaki
    Mio, Tadashi
    Adachi, Hirofumi
    Kozuki, Toshiyuki
    Sone, Takashi
    Seike, Masahiro
    Toyooka, Shinichi
    Kitagawa, Hiroshi
    Koto, Ryo
    Yamazaki, Satoshi
    Horinouchi, Hidehito
    THORACIC CANCER, 2024, 15 (20) : 1541 - 1552
  • [46] Induction concurrent chemoradiotherapy compared with induction radiotherapy for superior sulcus non-small cell lung cancer: a retrospective study
    Li, Jian
    Dai, Chun-Hua
    Shi, Shun-Bing
    Bao, Qian-Lei
    Yu, Li-Chao
    Wu, Jian-Rong
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2010, 6 (01) : 57 - 65
  • [47] Quality of life after VATS lung resection and SABR for early-stage non-small cell lung cancer: A longitudinal study
    Pompili, Cecilia
    Rogers, Zoe
    Absolom, Kate
    Holch, Patricia
    Clayton, Beverly
    Callister, Matthew
    Robson, Johnathan
    Brunelli, Alessandro
    Franks, Kevin
    Velikova, Galina
    LUNG CANCER, 2021, 162 : 71 - 78
  • [48] Population-based Treatment Patterns and Outcomes for Stage III Non-Small Cell Lung Cancer Patients A Real-world Evidence Study
    Yusuf, Dimas
    Walton, Ryan N.
    Hurry, Manjusha
    Farrer, Christie
    Bebb, D. Gwyn
    Cheung, Winson Y.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (09): : 615 - 620
  • [49] Long-term Surgical Outcomes in Oligometastatic Non-small Cell Lung Cancer: A Single-Center Study
    Yoo, Seungmo
    Cho, Won Chul
    Lee, Geun Dong
    Choi, Sehoon
    Kim, Hyeong Ryul
    Kim, Yong-Hee
    Kim, Dong Kwan
    Park, Seung-Il
    Yun, Jae Kwang
    JOURNAL OF CHEST SURGERY, 2023, 56 (01): : 25 - 32
  • [50] Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Non-Small Cell Lung Cancer - NEOSTAR Study
    Sepesi, B.
    Cascone, T.
    William, W.
    Lin, H.
    Leung, C.
    Weissferdt, A.
    Walsh, G.
    Rice, D.
    Roth, J.
    Mehran, R.
    Hofstetter, W.
    Antonoff, M.
    Fossella, F.
    Mott, F.
    Le, X.
    Skoulidis, F.
    Zhang, J.
    Byers, L.
    Lam, V.
    Glisson, B.
    Kurie, J.
    Blumenschein, G.
    Tsao, A.
    Lu, C.
    Altan, M.
    Elamin, Y.
    Gibbons, D.
    Papadimitrakopoulou, V.
    Lee, J.
    Heymach, J.
    Vaporciyan, A.
    Swisher, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S241 - S242